List of Tables
Table 1. Global Direct Acting Antivirals Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Direct Acting Antivirals Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Direct Acting Antivirals Market Competitive Situation by Manufacturers in 2025
Table 4. Global Direct Acting Antivirals Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Direct Acting Antivirals Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Direct Acting Antivirals Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Direct Acting Antivirals Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Direct Acting Antivirals Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Direct Acting Antivirals, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Direct Acting Antivirals, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Direct Acting Antivirals, Product Types and Applications
Table 12. Global Key Manufacturers of Direct Acting Antivirals, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Direct Acting Antivirals Companies by Tier (Tier 1, Tier 2, Tier 3), based on Direct Acting Antivirals Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Direct Acting Antivirals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Direct Acting Antivirals Sales by Region (K Units), 2021–2026
Table 18. Global Direct Acting Antivirals Sales Market Share by Region (2021–2026)
Table 19. Global Direct Acting Antivirals Sales by Region (K Units), 2027–2032
Table 20. Global Direct Acting Antivirals Sales Market Share by Region (2027–2032)
Table 21. Global Direct Acting Antivirals Revenue by Region (US$ Million), 2021–2026
Table 22. Global Direct Acting Antivirals Revenue Market Share by Region (2021–2026)
Table 23. Global Direct Acting Antivirals Revenue by Region (US$ Million), 2027–2032
Table 24. Global Direct Acting Antivirals Revenue Market Share by Region (2027–2032)
Table 25. North America Direct Acting Antivirals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Direct Acting Antivirals Sales by Country (K Units), 2021–2026
Table 27. North America Direct Acting Antivirals Sales by Country (K Units), 2027–2032
Table 28. North America Direct Acting Antivirals Revenue by Country (US$ Million), 2021–2026
Table 29. North America Direct Acting Antivirals Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Direct Acting Antivirals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Direct Acting Antivirals Sales by Country (K Units), 2021–2026
Table 32. Europe Direct Acting Antivirals Sales by Country (K Units), 2027–2032
Table 33. Europe Direct Acting Antivirals Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Direct Acting Antivirals Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Direct Acting Antivirals Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Direct Acting Antivirals Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Direct Acting Antivirals Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Direct Acting Antivirals Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Direct Acting Antivirals Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Direct Acting Antivirals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Direct Acting Antivirals Sales by Country (K Units), 2021–2026
Table 42. Latin America Direct Acting Antivirals Sales by Country (K Units), 2027–2032
Table 43. Latin America Direct Acting Antivirals Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Direct Acting Antivirals Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Direct Acting Antivirals Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Direct Acting Antivirals Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Direct Acting Antivirals Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Direct Acting Antivirals Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Direct Acting Antivirals Revenue by Country (US$ Million), 2027–2032
Table 50. Global Direct Acting Antivirals Sales (K Units) by Type (2021–2026)
Table 51. Global Direct Acting Antivirals Sales (K Units) by Type (2027–2032)
Table 52. Global Direct Acting Antivirals Sales Market Share by Type (2021–2026)
Table 53. Global Direct Acting Antivirals Sales Market Share by Type (2027–2032)
Table 54. Global Direct Acting Antivirals Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Direct Acting Antivirals Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Direct Acting Antivirals Revenue Market Share by Type (2021–2026)
Table 57. Global Direct Acting Antivirals Revenue Market Share by Type (2027–2032)
Table 58. Global Direct Acting Antivirals Price (US$/Unit) by Type (2021–2026)
Table 59. Global Direct Acting Antivirals Price (US$/Unit) by Type (2027–2032)
Table 60. Global Direct Acting Antivirals Sales (K Units) by Application (2021–2026)
Table 61. Global Direct Acting Antivirals Sales (K Units) by Application (2027–2032)
Table 62. Global Direct Acting Antivirals Sales Market Share by Application (2021–2026)
Table 63. Global Direct Acting Antivirals Sales Market Share by Application (2027–2032)
Table 64. Global Direct Acting Antivirals Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Direct Acting Antivirals Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Direct Acting Antivirals Revenue Market Share by Application (2021–2026)
Table 67. Global Direct Acting Antivirals Revenue Market Share by Application (2027–2032)
Table 68. Global Direct Acting Antivirals Price (US$/Unit) by Application (2021–2026)
Table 69. Global Direct Acting Antivirals Price (US$/Unit) by Application (2027–2032)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Gilead Sciences Direct Acting Antivirals Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. Asegua Therapeutics Company Information
Table 76. Asegua Therapeutics Description and Business Overview
Table 77. Asegua Therapeutics Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Asegua Therapeutics Direct Acting Antivirals Product
Table 79. Asegua Therapeutics Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Merck Direct Acting Antivirals Product
Table 84. Merck Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. AbbVie Direct Acting Antivirals Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Bristol Myers Squibb Company Information
Table 91. Bristol Myers Squibb Description and Business Overview
Table 92. Bristol Myers Squibb Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Bristol Myers Squibb Direct Acting Antivirals Product
Table 94. Bristol Myers Squibb Recent Developments/Updates
Table 95. Ascletis Pharma Company Information
Table 96. Ascletis Pharma Description and Business Overview
Table 97. Ascletis Pharma Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Ascletis Pharma Direct Acting Antivirals Product
Table 99. Ascletis Pharma Recent Developments/Updates
Table 100. Kawin Technology Company Information
Table 101. Kawin Technology Description and Business Overview
Table 102. Kawin Technology Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Kawin Technology Direct Acting Antivirals Product
Table 104. Kawin Technology Recent Developments/Updates
Table 105. YiChang HEC ChangJiang Pharmaceutical Company Information
Table 106. YiChang HEC ChangJiang Pharmaceutical Description and Business Overview
Table 107. YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. YiChang HEC ChangJiang Pharmaceutical Direct Acting Antivirals Product
Table 109. YiChang HEC ChangJiang Pharmaceutical Recent Developments/Updates
Table 110. Sanhome Pharmaceutical Company Information
Table 111. Sanhome Pharmaceutical Description and Business Overview
Table 112. Sanhome Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Sanhome Pharmaceutical Direct Acting Antivirals Product
Table 114. Sanhome Pharmaceutical Recent Developments/Updates
Table 115. Chia Tai Tianqing Pharmaceutical Company Information
Table 116. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 117. Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Chia Tai Tianqing Pharmaceutical Direct Acting Antivirals Product
Table 119. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 120. Cosunter pharmaceutical Company Information
Table 121. Cosunter pharmaceutical Description and Business Overview
Table 122. Cosunter pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Cosunter pharmaceutical Direct Acting Antivirals Product
Table 124. Cosunter pharmaceutical Recent Developments/Updates
Table 125. Beijing Sihuan Pharmaceutical Company Information
Table 126. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 127. Beijing Sihuan Pharmaceutical Direct Acting Antivirals Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Beijing Sihuan Pharmaceutical Direct Acting Antivirals Product
Table 129. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Direct Acting Antivirals Distributors List
Table 133. Direct Acting Antivirals Customers List
Table 134. Direct Acting Antivirals Market Trends
Table 135. Direct Acting Antivirals Market Drivers
Table 136. Direct Acting Antivirals Market Challenges
Table 137. Direct Acting Antivirals Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Direct Acting Antivirals
Figure 2. Global Direct Acting Antivirals Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Direct Acting Antivirals Market Share by Type: 2025 & 2032
Figure 4. Pangenotypic Product Picture
Figure 5. Genotype-Specific Product Picture
Figure 6. Global Direct Acting Antivirals Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Direct Acting Antivirals Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Direct Acting Antivirals Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Direct Acting Antivirals Market Size (US$ Million), 2021–2032
Figure 13. Global Direct Acting Antivirals Sales (K Units), 2021–2032
Figure 14. Global Direct Acting Antivirals Average Price (US$/Unit), 2021–2032
Figure 15. Direct Acting Antivirals Report Years Considered
Figure 16. Direct Acting Antivirals Sales Share by Manufacturers in 2025
Figure 17. Global Direct Acting Antivirals Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Direct Acting Antivirals Players: Market Share by Revenue in Direct Acting Antivirals in 2025
Figure 19. Direct Acting Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Direct Acting Antivirals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Direct Acting Antivirals Sales Market Share by Country (2021–2032)
Figure 22. North America Direct Acting Antivirals Revenue Market Share by Country (2021–2032)
Figure 23. United States Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Direct Acting Antivirals Sales Market Share by Country (2021–2032)
Figure 26. Europe Direct Acting Antivirals Revenue Market Share by Country (2021–2032)
Figure 27. Germany Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Direct Acting Antivirals Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Direct Acting Antivirals Revenue Market Share by Region (2021–2032)
Figure 34. China Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Direct Acting Antivirals Sales Market Share by Country (2021–2032)
Figure 42. Latin America Direct Acting Antivirals Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Direct Acting Antivirals Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Direct Acting Antivirals Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Direct Acting Antivirals Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Direct Acting Antivirals by Type (2021–2032)
Figure 53. Global Revenue Market Share of Direct Acting Antivirals by Type (2021–2032)
Figure 54. Global Direct Acting Antivirals Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Direct Acting Antivirals by Application (2021–2032)
Figure 56. Global Revenue Market Share of Direct Acting Antivirals by Application (2021–2032)
Figure 57. Global Direct Acting Antivirals Price (US$/Unit) by Application (2021–2032)
Figure 58. Direct Acting Antivirals Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
